Form DEFA14A CVS HEALTH Corp

Go back to Form DEFA14A CVS HEALTH Corp

CVS Health's (CVS) Signify Health Deal to 'Bolster Health Services Business Growth' - Mizuho

September 6, 2022 12:35 PM EDT

Mizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS), saying the Signify Health deal bolsters health services business growth.

The analyst commented, "We believe this deal will accelerate CVS's value-based care initiatives through SGFY's proprietary platforms. As a reminder, at its investor day last December, CVS... More